protease-activated receptor-3 in podocytes Cytoprotective signaling by activated protein C requires

doi:10.1182/blood-2011-07-365973Prepublished online November 23, 2011;2012 119: 874-883€€€€Jochen Reiser, Hermann-Josef Grone, Charles T. Esmon, Peter P. Nawroth and Berend IsermannShahzad, Sandra Muller-Krebs, Vedat Schwenger, Bruce Gerlitz, Brian W. Grinnell, John H. Griffin, Thati Madhusudhan, Hongjie Wang, Beate K. Straub, Elisabeth Grone, Qianxing Zhou, Khurrum€

[1]  T. Madhusudhan,et al.  Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy. , 2011, Blood.

[2]  B. Molitoris,et al.  Activated protein C and acute kidney injury: Selective targeting of PAR-1. , 2009, Current drug targets.

[3]  Lee D. Hallagan,et al.  Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. , 2009, The Journal of clinical investigation.

[4]  H. Anders,et al.  Double-stranded DNA activates glomerular endothelial cells and enhances albumin permeability via a toll-like receptor-independent cytosolic DNA recognition pathway. , 2009, The American journal of pathology.

[5]  D. Frommhold,et al.  Hypercoagulability Inhibits Monocyte Transendothelial Migration Through Protease-Activated Receptor-1–, Phospholipase-Cβ–, Phosphoinositide 3-Kinase–, and Nitric Oxide–Dependent Signaling in Monocytes and Promotes Plaque Stability , 2009, Circulation.

[6]  J. Trejo,et al.  Proteases display biased agonism at protease-activated receptors: location matters! , 2009, Molecular interventions.

[7]  José A Fernández,et al.  Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity , 2009, The European journal of neuroscience.

[8]  S. Shankland,et al.  Inducible rodent models of acquired podocyte diseases. , 2009, American journal of physiology. Renal physiology.

[9]  Hiroshi Deguchi,et al.  Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells , 2009, Proceedings of the National Academy of Sciences.

[10]  Kwanghee Kim,et al.  The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A , 2008, Nature Medicine.

[11]  J. Bae,et al.  Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells , 2008, Journal of thrombosis and haemostasis : JTH.

[12]  G. Reiser,et al.  The protease-activated receptor-3 (PAR-3) can signal autonomously to induce interleukin-8 release , 2008, Cellular and Molecular Life Sciences.

[13]  P. Carmeliet,et al.  Modification of kidney barrier function by the urokinase receptor , 2008, Nature Medicine.

[14]  C. Derian,et al.  'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage , 2007, Nature Immunology.

[15]  J. Bae,et al.  The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. , 2007, Blood.

[16]  L. O'Brien,et al.  Activated Protein C Decreases Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand by an EPCR- Independent Mechanism Involving Egr-1/Erk-1/2 Activation , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[17]  C. Esmon,et al.  Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis , 2007, Nature Medicine.

[18]  B. Molitoris,et al.  Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. , 2007, American journal of physiology. Renal physiology.

[19]  J. Griffin,et al.  The cytoprotective protein C pathway. , 2007, Blood.

[20]  A. Malik,et al.  Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization , 2007, Proceedings of the National Academy of Sciences.

[21]  G. Sandusky,et al.  Role of protein C in renal dysfunction after polymicrobial sepsis. , 2007, Journal of the American Society of Nephrology : JASN.

[22]  J. Bae,et al.  Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells , 2007, Proceedings of the National Academy of Sciences.

[23]  J. Garcia,et al.  Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement , 2005, Journal of Biological Chemistry.

[24]  C. Feistritzer,et al.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. , 2005, Blood.

[25]  C. Esmon,et al.  PAR1 Cleavage and Signaling in Response to Activated Protein C and Thrombin* , 2005, Journal of Biological Chemistry.

[26]  P. Henklein,et al.  Proteinase-activated receptors (PARs)—the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1 , 2005, Regulatory Peptides.

[27]  M. Hollenberg,et al.  Tethered ligand‐derived peptides of proteinase‐activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells , 2004, Immunology.

[28]  José A Fernández,et al.  Activated Protein C Prevents Neuronal Apoptosis via Protease Activated Receptors 1 and 3 , 2004, Neuron.

[29]  M. Francolini,et al.  Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains , 2003, Oncogene.

[30]  K. Schrör,et al.  Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells , 2003, Thrombosis and Haemostasis.

[31]  Joseph Parello,et al.  Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. , 2003, Journal of molecular biology.

[32]  B. Isermann,et al.  The thrombomodulin–protein C system is essential for the maintenance of pregnancy , 2003, Nature Medicine.

[33]  Matthias Kretzler,et al.  Cell biology of the glomerular podocyte. , 2003, Physiological reviews.

[34]  W. Ruf,et al.  Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.

[35]  M. O'hare,et al.  A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. , 2002, Journal of the American Society of Nephrology : JASN.

[36]  A. Kuliopulos,et al.  Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Bar-Shavit,et al.  Signalling pathways induced by protease‐activated receptors and integrins in T cells , 2002, Immunology.

[38]  P. L. Becker,et al.  Cholesterol Depletion Inhibits Epidermal Growth Factor Receptor Transactivation by Angiotensin II in Vascular Smooth Muscle Cells , 2001, The Journal of Biological Chemistry.

[39]  S. Coughlin,et al.  PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.

[40]  S. Okumura,et al.  Colocalization of β‐adrenergic receptors and caveolin within the plasma membrane , 1999 .